Zawadzka-Starczewska Katarzyna, Tymoniuk Bogusław, Stasiak Bartłomiej, Lewiński Andrzej, Stasiak Magdalena
Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital-Research Institute, 281/289 Rzgowska St., 93-338 Lodz, Poland.
Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.
J Clin Med. 2022 Apr 29;11(9):2492. doi: 10.3390/jcm11092492.
The association between HLA and the risk of Graves' disease (GD) has been analyzed for many years. However, the results were often inconsistent and mostly regarded Asian populations. The purpose of our study was to perform HLA genotyping using a next-generation sequencing (NGS) method in Caucasians, to find out which alleles are eventually correlated with GD morbidity as well as which of them can be considered protective. were genotyped using a next-generation sequencing method in 2376 persons, including 159 GD patients and 2217 healthy controls. We have demonstrated a significant association between the risk of GD and the following alleles: . The alleles are novel GD-associated, previously not-reported independent ones with no linkage disequilibrium with other high-risk alleles. On the other hand, the frequencies of were significantly lower in GD compared to controls. This study demonstrated the actual relationships between HLA and GD based on the NGS method and provided a novel set of alleles as a reliable tool for an individual personalized risk assessment.
多年来一直在分析HLA与格雷夫斯病(GD)风险之间的关联。然而,结果往往不一致,且大多针对亚洲人群。我们研究的目的是在白种人中使用下一代测序(NGS)方法进行HLA基因分型,以找出最终与GD发病率相关的等位基因,以及其中哪些可被视为具有保护作用。在2376人中使用下一代测序方法进行基因分型,包括159例GD患者和2217名健康对照。我们已经证明GD风险与以下等位基因之间存在显著关联: 。这些等位基因是新的与GD相关的、以前未报告的独立等位基因,与其他高风险等位基因无连锁不平衡。另一方面,与对照组相比,GD中 的频率显著更低。本研究基于NGS方法证明了HLA与GD之间的实际关系,并提供了一组新的等位基因作为个体个性化风险评估的可靠工具。